<DOC>
	<DOCNO>NCT00442026</DOCNO>
	<brief_summary>This trial compare efficacy docetaxel gemcitabine combination versus monotherapy gemcitabine first-line treatment elderly patient advance NSCLC</brief_summary>
	<brief_title>Randomized Trial Docetaxel Gemcitabine Versus Gemcitabine Elderly Patients With NSCLC</brief_title>
	<detailed_description>Docetaxel gemcitabine well know active agent treatment NSCLC . The standard treatment elderly patient advance NSCLC monotherapy third generation agent . However , randomized trial evaluate two drug combination specifically address elderly patient . The role comprehensive geriatric assessment treatment efficacy tolerance area investigation</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Histologically cytologically confirm NonSmallCell Lung Cancer Stage IIIB/IV No prior chemotherapy Presence twodimensional measurable disease . The measurable disease irradiate . Absence irradiate stable central nervous system metastatic disease Life expectancy 3 month Age â‰¥ 70 year . Performance status ( WHO ) &lt; 3 Patients `` nonfrail '' accord comprehensive geriatric assessment Adequate bone marrow function ( Absolute neutrophil count &gt; 1000/mm^3 , Platelet count &gt; 100000/mm^3 , Hemoglobin &gt; 9gr/mm^3 ) . Adequate liver ( Bilirubin &lt; 1.5 time upper limit normal SGOT/SGPT &lt; 2 time upper limit normal ) renal function ( creatinine &lt; 2mg/dl ) . Adequate cardiac function ( LVEF &gt; 50 % ) . Informed consent . Psychiatric illness social situation would preclude study compliance . Other concurrent uncontrolled illness . Other invasive malignancy within past 5 year except nonmelanoma skin cancer . No presence reliable care giver Other concurrent investigational agent .</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Cancer</keyword>
	<keyword>NSCLC</keyword>
	<keyword>Elderly</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Docetaxel</keyword>
	<keyword>Gemcitabine</keyword>
</DOC>